Recruiting

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Sponsor:

Yale University

Code:

NCT06172660

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 0 - 12

Healthy Volunteers: Not accepted

Interventions

Nirsevimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by Yale University on 2024-10-08.